$DOC · HEALTHPEAK PROPERTIES, INC.
Healthpeak Properties filed its Q3 2026 10-Q, reporting $820.9M in total revenue (+16.3% YoY) with GAAP EPS of $0.02. The quarter reflects the full consolidation of Janus Living, driving resident fees and services to $268.3M from $150.5M a year ago. Total equity rose to $10.78B, boosted by $3.09B in noncontrolling interest issuances tied to the Janus Living IPO and joint venture activity.
- Q3 revenue hit $820.9M, +16.3% YoY, driven by resident fees and services nearly doubling to $268.3M from $150.5M.
- GAAP net income attributable to common shares was just $17.1M ($0.02/share), down from a $117.3M loss a year ago but razor-thin.
- Total noncontrolling interests ballooned to $2.91B from $643M at year-end 2025, reflecting the Janus Living IPO and JV partner contributions.
- Nine-month other income swung to +$165.2M from -$9.7M, largely from a $138.3M gain on change of control.
- The company repurchased 6.0M shares for $101.7M during the nine months while paying $0.915/share in common dividends.
Extended-hours trading shows DOC at $19.56, essentially flat vs the regular close of $19.56. The thin GAAP EPS of $0.02 likely tempers enthusiasm around the strong 16.3% revenue growth, keeping the $13.49B market-cap REIT rangebound after hours.
The Janus Living consolidation is transforming Healthpeak's revenue mix toward operating-heavy senior housing, but razor-thin GAAP profitability raises questions about the model's margin trajectory.
Healthpeak's senior-housing ramp mirrors the broader healthcare REIT pivot toward operating-intensive models. The Janus Living IPO and noncontrolling interest expansion to $2.91B suggest a capital-light strategy similar to peers Welltower and Ventas.
Senior housing operating expenses surged to $379.4M from $291.9M YoY, reflecting the cost burden of scaling resident fees and services. Transaction costs tripled to $9.7M in Q3 and $43.1M year-to-date, signaling integration complexity from the Janus Living consolidation.